NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)

The National Institute of Neurological Disorders and Stroke (NINDS) is soliciting grant applications for investigator-initiated exploratory clinical trials. The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications are eligible to apply. The grant supports STTR Phase II and Fast-Track applications, but not STTR Phase I applications unless part of a Fast-track application. Key aspects of this opportunity include: • Investigator-initiated exploratory clinical trials • Products related to NINDS mission and goals • Evaluation of various treatments and therapies • Eligibility limited to Small Business Concerns (SBCs) with STTR grant applications • Support for STTR Phase II and Fast-Track applications